Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 292.56M
March 31, 2026 294.39M
December 31, 2025 285.25M
September 30, 2025 278.64M
June 30, 2025 234.19M
March 31, 2025 239.32M
December 31, 2024 224.08M
September 30, 2024 252.93M
June 30, 2024 220.21M
March 31, 2024 291.99M
December 31, 2023 259.24M
September 30, 2023 306.34M
June 30, 2023 168.02M
March 31, 2023 195.33M
December 31, 2022 178.20M
September 30, 2022 186.52M
June 30, 2022 185.83M
March 31, 2022 189.44M
December 31, 2021 139.11M
September 30, 2021 117.07M
June 30, 2021 138.54M
March 31, 2021 117.57M
December 31, 2020 109.68M
September 30, 2020 102.85M
June 30, 2020 102.55M
Date Value
March 31, 2020 71.20M
December 31, 2019 89.52M
September 30, 2019 102.43M
June 30, 2019 127.36M
March 31, 2019 86.08M
December 31, 2018 93.32M
September 30, 2018 75.72M
June 30, 2018 55.04M
March 31, 2018 61.53M
December 31, 2017 72.38M
September 30, 2017 73.60M
June 30, 2017 87.43M
March 31, 2017 79.03M
December 31, 2016 74.27M
September 30, 2016 68.84M
June 30, 2016 68.05M
March 31, 2016 64.62M
December 31, 2015 67.36M
September 30, 2015 71.97M
June 30, 2015 75.75M
March 31, 2015 70.08M
December 31, 2014 69.32M
September 30, 2014 74.38M
June 30, 2014 65.58M
March 31, 2014 53.46M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 1.410B
Supernus Pharmaceuticals, Inc. 372.07M
Liquidia Corp. 284.18M
ANI Pharmaceuticals, Inc. 375.87M
Corcept Therapeutics, Inc. 308.20M